Literature DB >> 29413470

Negative phase 3 study of 90Y microspheres versus sorafenib in HCC.

Josep M Llovet1, Richard S Finn2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29413470     DOI: 10.1016/S1470-2045(18)30025-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.

Authors:  Linzi Arndt Webster; Alexander Villalobos; Bill S Majdalany; Zachary L Bercu; Ripal T Gandhi; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

2.  Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.

Authors:  Matthew Walton; Ros Wade; Lindsay Claxton; Sahar Sharif-Hurst; Melissa Harden; Jai Patel; Ian Rowe; Robert Hodgson; Alison Eastwood
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

Review 3.  Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.

Authors:  Josep M Llovet; Thierry De Baere; Laura Kulik; Philipp K Haber; Tim F Greten; Tim Meyer; Riccardo Lencioni
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-28       Impact factor: 46.802

Review 4.  Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update.

Authors:  Sirish A Kishore; Raazi Bajwa; David C Madoff
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.